Parkinson's Disease clinical trials in Connecticut
17 active Parkinson's Disease trials with a site in Connecticut. Describe your situation to see which ones look like a fit.
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Imaging Depression in Parkinson's Disease
- A Study of Buntanetap in Participants With PD
- Neurologic Stem Cell Treatment Study
- Daily Amino Acid Supplementation for People With Parkinson's Disease
- Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
- Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
- Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
- Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
- Parkinson's Foundation PD GENEration Genetic Registry
- Intestinal Immunity in Neurologic Disease
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Long Term Follow Up KET-PD
- Cognitive Effects of Exercise in Parkinson's Disease
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.